These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20931407)

  • 1. Neurobiological bases of quetiapine antidepresant effect in the bipolar disorder.
    Prieto E; Micó JA; Meana JJ; Majadas S
    Actas Esp Psiquiatr; 2010; 38(1):22-32. PubMed ID: 20931407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine.
    Khouzam HR; Singh F
    Expert Rev Neurother; 2006 Feb; 6(2):131-44. PubMed ID: 16466293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of quetiapine extended release in the treatment of bipolar depression.
    Cristancho MA; Thase ME
    Adv Ther; 2010 Nov; 27(11):774-84. PubMed ID: 20835785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of quetiapine for treatment-resistant bipolar disorder: a case series.
    Ghaemi SN; Katzow JJ
    Ann Clin Psychiatry; 1999 Sep; 11(3):137-40. PubMed ID: 10482123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preclinical and clinical rationale for quetiapine in mood syndromes.
    McIntyre RS; Soczynska JK; Woldeyohannes HO; Alsuwaidan M; Konarski JZ
    Expert Opin Pharmacother; 2007 Jun; 8(9):1211-9. PubMed ID: 17563257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression.
    Todder D; Caliskan S; Baune BT
    J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.
    Vieta E
    Hum Psychopharmacol; 2005 Jun; 20(4):225-36. PubMed ID: 15880391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
    Björkholm C; Jardemark K; Marcus MM; Malmerfelt A; Nyberg S; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):709-20. PubMed ID: 22732518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quetiapine in substance use disorders, abuse and dependence possibility: a review].
    Erdoğan S
    Turk Psikiyatri Derg; 2010; 21(2):167-75. PubMed ID: 20514567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine monotherapy for bipolar depression.
    Janicak PG; Rado JT
    Expert Opin Pharmacother; 2011 Jul; 12(10):1643-51. PubMed ID: 21609188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
    Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
    J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S; Lykouras L
    J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.